MR Molecular Imaging of Prostate Cancer with a Peptide-Targeted Contrast Agent in a Mouse Orthotopic Prostate Cancer Model

Author： Tan Mingqian   Burden-Gulley Susan   Li Wen   Wu Xueming   Lindner Daniel   Brady-Kalnay Susann   Gulani Vikas   Lu Zheng-Rong  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.29, Iss.4, 2012-04, pp. : 953-960

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear Imaging of Prostate Cancer with Gastrin-Releasing-Peptide- Receptor Targeted Radiopharmaceuticals

By  

Current Pharmaceutical Design, Vol. 14, Iss. 28, 2008-10 ,pp. : 3033-3047

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Lily-of-the-Valley Fragrance Contrast Agent for Magnetic Resonance and Fluorescence Imaging of Prostate Cancer Cells

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 2, 2012-02 ,pp. : 373-377

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies for prostate cancer

By Asatiani Ekatherine   Gelmann Edward P  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 283-298

Informa Healthcare

Access to resources Recommend Favorite

Capromab Pendetide: A Review of its Use as an Imaging Agent in Prostate Cancer

By Lamb H.M.   Faulds D.  

Drugs & Aging, Vol. 12, Iss. 4, 1998-04 ,pp. : 293-304

Adis International

Access to resources Recommend Favorite

Role of Imaging in Prostate Cancer: A Review

By Jeschke S.   Schweigreiter E.   Janetschek G.  

Imaging Decisions MRI, Vol. 13, Iss. 3-4, 2009-0 ,pp. : 68-87

Blackwell Publishing

Access to resources Recommend Favorite